FDA Approves Olympus Scope Modifications Intended to Reduce Infection Risk

Medical device litigation
Ohio's Defective Medical Device Attorney - Borgess Law, LLC

On January 15, 2016, the U.S. Food and Drug Administration (FDA) cleared the Olympus TJF-Q180V duodenoscope with modifications to the device’s design and labeling intended to help reduce the risk of bacterial infections. (1/15/16 FDA News Release)  Olympus will voluntarily recall its original model currently being used in health care facilities and make the needed…

Read More